Carregant...
Targeting the Ras pathway in pediatric hematologic malignancies
PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...
Guardat en:
| Publicat a: | Curr Opin Pediatr |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/ https://ncbi.nlm.nih.gov/pubmed/33394740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|